Mizuho Maintains Neutral on Doximity, Lowers Price Target to $26

Benzinga Newsdesk www.benzinga.com Negative 74.0%

Neg 74% Neu 0% Pos 0%

Mizuho analyst Steven Valiquette maintains Doximity (NYSE:DOCS) with a Neutral and lowers the price target from $34 to $26.